Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xolair in severe paediatric atopic eczema
NCT02300701Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Dec 2014
- Primary completion
- Aug 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in atopic dermatitis (AD), sponsored by Guy's and St Thomas' NHS Foundation Trust. Started Dec 2014; status: completed.
02
Drugs
omalizumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02300701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02300701.